All Articles

Controlled attenuation parameter factors and steatosis grading in metabolic dysfunction-associated steatotic liver disease

Emerging potential of CAR-NK cell therapy for hepatocellular carcinoma: current advances and translational challenges

Functional cure of chronic hepatitis B virus infection: current therapeutic regimens

A baseline-lymphocyte-subset nomogram for predicting severe immune-related adverse events in hepatocellular carcinoma patients receiving TACE plus immunotherapy

Artificial intelligence for enhancing decision-making in multidisciplinary tumor boards for HCC in China

The multiparametric therapeutic hierarchy: a multidisciplinary approach to HCC management

Thermal ablation therapy for hepatocellular carcinoma: recurrence mechanisms and intervention strategies

Immune microenvironment and immunotherapy strategies in MAFLD-related hepatocellular carcinoma

Price threshold analysis of biomarker surveillance for hepatocellular carcinoma in Australia

Oncolytic virus VG161 brings new hope for advanced HCC

The importance of patient fitness in expert and multidisciplinary multiparametric management of HCC: a narrative review

Burden of liver cancer in adolescents and young adults aged 15-49 years in China: a comprehensive analysis based on the Global Burden of Disease study (1990-2021)

Glucose metabolic dysregulation and oxidative stress in cholangiocarcinoma: molecular mechanisms, oncogenic drivers, and novel therapeutic targets

Cancer stem cells in cholangiocarcinoma: emerging roles as therapeutic targets

The new era of cholangiocarcinoma treatment: application of nano-based drug delivery systems

Influence of the gut microbiota on the response to immunotherapy in hepatocellular carcinoma

Functions and potential clinical applications of circular RNAs in hepatocellular carcinoma

Importance of critical tumor features in multidisciplinary multi-parametric assessment of HCC